The Breast Site Group at Princess Margaret aims to continuously advance the frontiers of clinical and translational research to provide innovative treatment and management in medical, radiation and surgical oncology. Our key areas of research are clinical trials and drug development, translational research, quality of life and supportive care.
We have a large clinical trials program, ranging from multi-centre Phase III trials to Phase I and II trials, which are led by Breast Site Group members.
